Semax vs Selank: Mechanisms, Evidence and Key Differences

Semax and Selank are both synthetic seven-amino-acid peptides developed from naturally occurring peptide fragments, but their research profiles are different. Semax is derived from the ACTH(4-7) fragment and is investigated mainly in neurotrophic, neuroprotective and cognitive research. Selank is derived from the immunomodulatory peptide tuftsin and is investigated mainly in anxiety, stress and GABA-related research.

The simplest comparison is: Semax research centres on neurotrophin signalling and responses to neurological stress, while Selank research centres on GABAergic modulation, anxiety-related behaviour and enkephalin metabolism. Neither distinction means that every popular claim has been established in large modern clinical trials.

This Semax vs Selank guide compares sequence, origin, proposed mechanisms, evidence and practical research differences. For a broader classification, visit our guide to types of peptides.

Semax vs Selank: Quick Comparison

What Is Semax?

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. The first four residues correspond to the ACTH(4-7) fragment, while the C-terminal Pro-Gly-Pro sequence improves resistance to rapid enzymatic breakdown.

Unlike full adrenocorticotropic hormone, Semax does not include the complete ACTH sequence. Its research identity is therefore associated with neuroactive peptide signalling rather than the full endocrine activity of ACTH.

Why Semax is studied

Semax is studied in models involving:

• brain-derived neurotrophic factor (BDNF);
• nerve growth factor (NGF);
• Trk neurotrophin receptors;
• ischemic and oxidative stress;
• learning and memory pathways;
• neuroinflammatory gene expression.

In rat research, Semax produced time- and tissue-dependent changes in BDNF and NGF gene expression in the hippocampus, frontal cortex and retina (Shadrina et al., 2010). Another ischemia model found changes in transcription of neurotrophins and their receptors after Semax exposure (Dmitrieva et al.).

These studies support investigation of neurotrophin-related mechanisms, but gene-expression changes in rodents are not equivalent to proven cognitive enhancement in healthy humans.

What Is Selank?

Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is based on tuftsin, a naturally occurring tetrapeptide involved in immune signalling, with a Pro-Gly-Pro extension that increases metabolic stability.

Why Selank is studied

Selank research commonly examines:

• GABA-related neurotransmission;
• anxiety and stress-related behaviour;
• expression of neurotransmitter receptor and transporter genes;
• enkephalin-degrading enzymes;
• interactions between nervous and immune signalling.

A rat frontal-cortex study found that Selank altered expression of genes involved in neurotransmission and reported overlap with changes observed after GABA administration. The authors proposed a mechanism involving modulation of the GABAergic system (Volkova et al., 2016).

Separate laboratory research found that Selank affected GABA binding as a positive allosteric modulator under the tested conditions (Vyunova et al., 2018). Another study reported inhibition of enkephalin-degrading enzymes in human plasma in vitro (Zozulya et al., 2001).

These findings describe plausible mechanisms; they do not establish that Selank behaves like a conventional anxiolytic in every human setting.

The Key Structural Difference

Semax and Selank share the Pro-Gly-Pro tripeptide at the C-terminus, but the four N-terminal amino acids differ:

• Semax: Met-Glu-His-Phe—derived from ACTH(4-7);
• Selank: Thr-Lys-Pro-Arg—derived from tuftsin.

That difference changes charge, conformation, metabolic interactions and biological targets. The shared “-PGP” ending does not make the two peptides interchangeable.

Semax Mechanism of Action

Neurotrophin gene expression

The strongest recurring mechanistic theme is regulation of neurotrophin pathways, especially BDNF and NGF. Effects vary by tissue and sampling time, suggesting a dynamic signalling response rather than a simple permanent increase.

Responses to neural stress

Semax has been evaluated in animal models of cerebral ischemia and other forms of neural stress. Researchers have examined transcriptional changes, inflammatory signalling and functional recovery markers.

What remains uncertain

A large part of Semax’s mechanistic literature comes from rodents or cell-based research. Human studies exist, including neurological rehabilitation research, but many are relatively small, regionally published or not designed to answer healthy-cognition questions. Claims about focus, memory or mental energy should therefore be separated from evidence in stroke or injury models.

Selank Mechanism of Action

GABAergic modulation

Selank is investigated as a modulator of GABA-related signalling. The published work includes changes in gene expression and radioligand-binding experiments. “Modulator” is the careful term: Selank is not simply GABA itself, and the evidence does not show that it is identical to a benzodiazepine.

Enkephalin metabolism

Selank has also inhibited enkephalin-degrading activity under in-vitro conditions. Enkephalins participate in pain, stress and emotional processing, providing another possible research pathway.

What remains uncertain

The human evidence base is much smaller than the online discussion suggests. Preclinical anxiolytic signals and molecular mechanisms are valuable for hypothesis generation, but large independent trials using modern reporting standards remain limited.

Semax vs Selank for Cognitive Research

Semax is more directly associated with neurotrophin and neural-plasticity research. Selank is more directly associated with the relationship between anxiety, stress and cognition. That does not mean Semax is universally stimulating or Selank universally calming.

For experimental design:

• Semax may fit questions centred on BDNF, NGF, ischemic stress or learning-related pathways;
• Selank may fit questions centred on GABAergic signalling, anxiety models or stress-related behaviour;
• direct comparison requires the same model, endpoint, timing and analytical methods;
• subjective descriptions such as “focus” or “calm” are not substitutes for predefined outcomes.

Can Semax and Selank Be Studied Together?

Their different origins and proposed pathways create a mechanistic reason to study interactions. However, a plausible combination is not proof of synergy. Combination research must distinguish:

• additive effects from true synergy;
• beneficial pathway interaction from interference;
• molecular endpoints from behavioural outcomes;
• short-term changes from durable effects.

There is not a robust body of large controlled human research demonstrating that the combination is superior to either peptide alone.

Evidence Quality: Semax vs Selank

Both compounds have more mechanistic evidence than high-quality independent human outcome evidence.

Semax evidence strengths

• multiple mechanistic studies involving neurotrophin pathways;
• animal models with defined neurological stress;
• some human neurological and rehabilitation research.

Semax evidence limitations

• many studies originate from a relatively concentrated research network;
• preclinical endpoints are often generalized beyond their model;
• limited large independent trials for healthy cognitive enhancement.

Selank evidence strengths

• defined peptide sequence and proposed GABA-related mechanisms;
• gene-expression and receptor-binding research;
• some human anxiety-related literature.

Selank evidence limitations

• limited large, independent, well-reported clinical trials;
• heavy reliance on animal, in-vitro and mechanistic outcomes;
• popular claims that extend beyond the published endpoints.

Quality and Identity Matter in a Semax vs Selank Comparison

Because both are seven-amino-acid peptides and share a PGP ending, a product name is not enough. Reliable research should verify the complete molecular identity, chromatographic purity and batch-specific quantity.

Our guide to reading a peptide COA explains why HPLC purity is different from identity and vial content. The peptide storage and stability guide covers handling variables that can affect short peptides after testing.

Explore Semax and Selank

Great Northern Peptides offers research materials including Semax 10 mg and Selank 10 mg. Compare them by sequence, mechanism and evidence rather than treating “cognitive peptide” as one uniform category.

Frequently Asked Questions About Semax vs Selank